65,437 trials
Arteriovenous Malformations
Primary: Target Volume Difference Between Standard of Care vs. CT Angiogram and MRI Alone — 1.1; 1.3 mL
Bladder Cancer
Primary: Number of Participants With Grade 3, 4, and 5 Treatment Related Adverse Events — 0; 4; 3; 6 Participants
Non Small Cell Lung Cancer
Primary: Overall Survival — 19.2 Months
Asthma
Primary: Change in Percentage of Days Covered for Inhaled Corticosteroids — 51.5; 44.7; 37.0; 29.1 percentage of days — p=0.05
Device Malfunction · ICD · Pacemaker Lead Dysfunction
Primary: IVUS Grades — 1.33; 1; 1.57; 1.44 Grade — p=0.2201
Diabetes Mellitus, Type 1
Primary: Pharmacodynamics (PD): Change in Plasma Glucose (PG) From the Start to the End of Exercise — -26.8; -46.9; -39.0; -60.5 milligram per Deciliter (mg/dL) — p=0.0494
HCV · Buprenorphine · PreP
Primary: Hepatitis C Virus (HCV) Cure (Sustained Virologic Response) — 158 Participants
Fibromyalgia
Primary: Change in Widespread Pain Index (WPI) — 1.4 units on a scale
Platelet Dysfunction Due to Drugs
Primary: P2Y12 Reaction Units — 187.35 P2Y12 Reaction Units
Spinal Muscular Atrophy
Primary: Six Minute Walk Test (6MWT) With Kinematic Evaluation of Gait (Short Term) — 293.05; 299.50 meters
Ulcerative Colitis
Primary: Percentage of Participants With Adverse Events, Adverse Drug Reactions, Serious Adverse Events and Serious Adverse Drug Reactions — 40.19; 24.30; 7.48; 0.93 Percentage…
Anxiety · Depressive Symptoms · Stress, Emotional
Primary: Depression Anxiety and Stress Scale (DASS-21) — 16.9; 16.3; 16.5; 18.3 score on a scale — p=.008
Lung Cancer · Complication of Surgical Procedure
Primary: Postoperative Chest Drainage Volume up to Chest Drain Removal, Average 3 Days. — 550; 580 ml
Pulmonary Hypertension · Chronic Disease
Primary: Change in Pulmonary Arterial Hypertension Symptom Scale - SOB With Exertion — 3.0 units on a scale
Hiv
Primary: Tenofovir Diphosphate (TFV-DP) Levels in Plasma and Intracellular Levels in Pregnant Women on Daily PrEP — 580; 71 TFV-DP PBMC (fmol/10^6cells)